TruSight Oncology 500 is a next-generation sequencing tumor profiling assay that analyzes 523 genes for cancer-related biomarkers with FFPE samples. The assay supports the identification of DNA and RNA variants implicated in various tumor types, including measuring key immunotherapy biomarkers such as tumor mutation burden (TMB) and microsatellite instability (MSI). This webinar focuses on introducing TruSight Oncology 500/TruSight Oncology 500 HRD library preparation and is targeted at new users of the workflow. We cover the following topics: how to successfully prepare and sequence TruSight Oncology 500 libraries and changes in HRD workflow.

Speaker:

Wong Yuk Peng Technical Applications Scientist, Illumina Yuk Peng graduated from the National University of Singapore in 2007 majoring in Biomedical Sciences. She worked in a research lab as molecular biologist focused on the study of ion channels in the brains and hearts. She then moved to biotechnology company to provide technical support supporting both genomics and protein biochemistry products. Yuk Peng has joined Illumina as a Technical Application Scientist in December 2021.